Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; (NASDAQ: $HUGE) (CSE: $HUGE.C) (CSE: $HOLL.C) (CSE: $INDS.C) (TSXV: $KHRN.V) (TSX: $LABS.TO)
Delta, Kelowna, BC, February 20, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/02201HUGE-HOLL-INDS-KHRN-LABS.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we look at a few public announcements.
But first, High Times, the most well-known brand in Cannabis, announced today that it received notification from FINRA that it was granted a trading symbol, clearing a final hurdle to begin trading. Company trading will commence with a planned listing date to be determined in the near future. The approval provides Hightimes Holding Corp. the ability to list on the public markets which will culminate the brand’s highly successful Regulation A + campaign.
“This is a big step for the company and the High Times brand. The listing of the company’s stock will give us a trading currency that will assist us in furthering our acquisitional goals. There is no better time to roll out this next evolution as we enter the cannabis retail space,” Adam Levin, Executive Chairman of Hightimes Holding Corp., noted. “With the lessons we’ve learned from other operator’s mistakes, great management, and the current state of the industry, now is the time for High Times to thrive!“
“With over 23,000 investors, this has been one of the most widely subscribed to offerings in history - across any industry,” Levin continued. “We’ve proven the strength of our brand, and of the community we represent. We’re excited for this next step.”
High Times is committed to continuing to connect cannabis to consumers with trusted products, across price points, and has introduced several plans this year to support that. High Times aims to cement its place as the largest name in cannabis and become the ultimate destination for all consumers from the canna-curious to marijuana lifers - both in-store and in person. The continued expansion in licensing and e-commerce, and now into retail stores, allow the globally recognized brand the unique opportunity to reach consumers wherever they may live. With the first two retail stores launching in Los Angeles and Las Vegas, High Times’s digital presence provides worldwide reach.
“This feels just like my early days in ecommerce - except in this case we already have audience, and we’re dealing with the most well-known brand in Cannabis,” Stormy Simon, the brand’s Chief Executive Officer, stated. “My history in ecommerce should help the company as we develop both our retail business as well as our direct to consumer delivery options in markets across the globe.”
FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) announced the sale of its 12% equity interest in Cannara Biotech Inc. (CSE: LOVE) to a consortium of buyers for cash proceeds of more than $7.7 million.
The terms of the Share Sale Transaction were negotiated at arm's length with a group of buyers that included entities controlled by members of the Cannara board and senior management. A substantial portion of FSD Pharma's shareholdings in Cannara were subject to a statutory escrow expiring December 2021. Under the terms of the Share Sale Transaction, the buyers agreed to acquire FSD Pharma's interest subject to escrow and, as such, assumed all of the associated market risk. The Share Sale Transaction represents a 670% return on the Company's stake in Cannara.
"This is a very positive milestone for the shareholders and stakeholders of FSD Pharma to recognize a 7x return in less than two years," stated Raza Bokhari, MD, Executive Co-Chairman & CEO. "This transaction represents, which I hope is the first of others that will follow to strengthen our cash position on the balance sheet. Our aim is to scale up to $50 million in disposable cash through monetizing our non-cash assets and raising new capital from institutional and institutional grade investors in the United States and elsewhere."
Hollister Biosciences Inc. (CSE: HOLL), through its Hollister Cannabis Co division, announced the launch of its 5-pack of .5g hash-infused pre-rolls, HashBone MiniBones.
HashBones are the #1 hash-infused pre-roll in California. Each 1G HashBone is hand-packed with an artisan blend of 25% cold water bubble hash and 75% top-shelf flower. Each HashBone features a pair of sativa, hybrid or indica strains, boasting enhanced flavor and potency. Flower is sourced from California's Central Coast, while the cold-water bubble hash is made by Hollister.
The 5-pack of .5g hash-infused pre-rolls, HashBone MiniBones, will be distributed exclusively by Hollister Cannabis Co.'s distribution partner, Indus Holdings, Inc. (CSE: INDS) and is anticipated to launch by April 01, 2020 HashBone MiniBones are expected to retail at an average price of $30 (plus tax). Based on HashBone's current customer base, we forecast demand for 65,000 units in 2020.
The CEO of Hollister Biosciences Inc., Carl Saling shared, "Our customers have been requesting a multi pack HashBone that would be great on the go. We are thrilled to launch the 5-pack mini bone hash infused pre rolls. "
Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF) announced today its intent to bring the Company's Kuida® CBD brand to the Spanish market. This follows receipt of a "no objection" letter from the TSXV specific to Spain, and is subject to meeting all regulatory approvals in that country. With the previously announced fulfillment of E.U. cosmetic notification regulatory requirements Khiron will prepare to commercialize Kuida to a combined skincare market of over US$6.0 billion.
"As our European operations ramp up, we are able to bring our unique products, consumer experience and scientific capabilities from Latin America into one of the world's fastest growing markets. Entry for our Kuida brand into Spain, and later Switzerland, will represent another milestone in the Company's strategy to serve consumers across multiple categories and markets," comments Tejinder Virk, President, Khiron Europe.
Kuida, the first consumer brand of Khiron's wellness business unit, brings the benefits of cannabidiol (CBD) to a comprehensive portfolio of skin and body care products for women. Kuida was launched in Colombia in October 2018 through retail, wholesale and online channels and is now available nationwide and through e-commerce channels. As the Company expands Kuida distribution in Europe, an initial soft launch in the UK will be followed by a strategic marketing and retail campaign. Kuida will be a featured exhibitor at Cosmoprof Worldwide Bologna 2020, which attracted over 265,000 visitors in 2019 and is the largest such event for attendees to learn more about market leading products and to place orders.
MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) announced that Shoppers Drug Mart, Canada’s leading pharmacy retailer, has selected its wholly-owned subsidiary, MediPharm Labs Inc., to supply high-quality cannabis concentrate products to medical patients nationally in Canada through its online platform Medical Cannabis by Shoppers.
Under the terms of the agreement, MediPharm will utilize its proprietary pharmaceutical manufacturing platform, methodologies and scientific data to provide Medical Cannabis by Shoppers with a wide range of concentrate-based products starting with formulated bottled oils. MediPharm will provide other derivative products such as gel caps and topicals as they become available. The agreement is for a three-year term subject to renewal for an additional two years. Formulated oils provided under the agreement are expected to begin being shipped to Shoppers within the first two months of the agreement.
“MediPharm Labs is proud to be partnering with one of Canada’s most trusted names in retail to bring new and innovative pharmaceutical-quality cannabis concentrate products to Shoppers’ medical consumers across Canada,” said Pat McCutcheon, CEO, MediPharm Labs. “With our pharmaceutically trained team, our GMP certified platform and research licence permitting human trials, MediPharm Labs has the ability to develop advanced cannabis products backed by proprietary scientific research that will serve as the foundation for further expansion of future offerings.”
Medical Cannabis by Shoppers launched in January 2019. The platform ships products from Canadian licensed producers directly and discreetly to customers in all provinces and territories in Canada. Under current regulations, pharmacists cannot dispense medical cannabis from a pharmacy.
According to Statistics Canada, approximately 1.1 million Canadians use cannabis for medical purposes.i MediPharm Labs is pleased to partner with a retailer who is not only committed to providing patients with high-quality medical cannabis from a trusted source, but guidance from specialized advisors. Such guidance is important in ensuring patients achieve satisfaction with their customer experience.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Cannabis Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment